Donna Ambrosino
Fortune : 68 129 $ au 30/06/2026
Fortune : 68 129 $ au 30/06/2026
Donna Marie Ambrosino currently works at Clover Biopharmaceuticals Ltd., as Non-Executive Director from 2022.
Dr. Ambrosino also formerly worked at Visterra, Inc., as Chief Medical Officer from 2012 to 2014 and Harvard Medical School, as Associate Professor.
Dr. Ambrosino received her undergraduate degree from Harvard University and doctorate degree from Dartmouth Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 329 796 ( 0,03 % ) | 68 129 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 17/06/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| VISTERRA INC | Directeur Technique/Scientifique/R&D | 01/01/2014 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Visterra, Inc.
Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national